Latest news
KidneyCAN Congratulates 2026 KCRS Merit Award Recipients for Clinical Research - OncodailyOncodaily · Sun, 09 Aug 2026 17:34:20 GMTKura's Drug Combo Shows 13-Month Median Without Progression - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMTKura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026 - SahmSahm · Mon, 27 Jul 2026 07:00:00 GMT